NCT01488578 Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01458197 A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder. Status COMPLETED Phase PHASE2
NCT01437670 Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin Status COMPLETED Phase N/A
NCT01423838 Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder Status UNKNOWN Phase PHASE4
NCT01409512 Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder Status UNKNOWN Phase N/A
NCT01369485 Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder Status COMPLETED Phase NA
NCT01367886 Comparative Urine Proteomic Studies of Overactive Bladder in Humans Status COMPLETED Phase NA
NCT01302938 Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder Status TERMINATED Phase PHASE4
NCT01302067 A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine Status COMPLETED Phase PHASE4
NCT01294982 Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency Status COMPLETED Phase PHASE2
NCT01220726 Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction Status COMPLETED Phase PHASE3
NCT01214265 A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder Status COMPLETED Phase NA
NCT01210859 Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents Status WITHDRAWN Phase N/A
NCT01189071 Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain Status TERMINATED Phase NA
NCT01178827 Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial Status COMPLETED Phase PHASE4
NCT01175382 Combined Behavioral and Drug Treatment of Overactive Bladder in Men Status COMPLETED Phase PHASE2/PHASE3
NCT01167257 Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome Status COMPLETED Phase PHASE2